Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemoprevention in BRCA1 mutation carriers – proof of concept
2016-001087-11Phase 2Terminated
- Sponsor
- Belfast Health and Social Care Trust
- Start
- Sep 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tamoxifen, anastrozole, goserelin in breast cancer, sponsored by Belfast Health and Social Care Trust. Started Sep 2016; status: terminated.
02
Drugs
tamoxifenanastrozolegoserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2016-001087-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-001087-11.